UTI Healthcare Fund Direct Growth

UTI Healthcare Fund Direct Growth

Equity

UTI Mutual Fund

Sector - Healthcare

Get the latest NAV of UTI Healthcare Fund Direct Growth. View historical returns compared to its benchmark and category average. Know which stocks and sectors the fund is investing in. Get an estimate of returns from the SIP and lump sum returns calculator. View detailed holding analysis and peer comparison. Get INDmoney ranking of the fund.

₹319.06

▲0.1%1D

NAV as on 27 Jun 2025

16.44%/per year

Since Inception

Absolute Gain%

▲▼

314 people have invested ₹ 32.2L in UTI Healthcare Fund Direct Growth in the last three months

UTI Healthcare Fund Performance vs. Nifty 500

Fund returns vs Benchmark returns vs Category Average returns as on (27-Jun-25)

The fund has consistently outperformed the benchmark (Nifty 500) over the last 1Y, 3Y, 5Y time periods.

Period
This Fund
Nifty 500
Category Avg
1 Month
2.56%
3.52%
1.81%
3 Months
6.2%
10.33%
4.85%
6 Months
-2.28%
5.23%
-1.96%
1 Year
22.19%
4.8%
17.37%
3 Years
27.62%
20.66%
24.65%
5 Years
22.91%
22.51%
21.45%

INDmoney Rank

Powered by IND quant engine

IND ranking is not available for this fund.

Fund Name
INDmoney Rank
AUM (in Crs.)
Expense Ratio
1Y Returns
3Y Returns
Inception Returns
UTI Healthcare Fund
7/8
1,062Cr
1.28%
22.19%
27.62%
16.44%
SBI Healthcare Opportunities Fund Direct Growth
1/8
3,689Cr
0.9%
21.24%
30.02%
18.23%
ICICI Prudential Pharma Healthcare and Diagnostics P.H.D Fund Direct Growth
2/8
5,508Cr
1.06%
23.69%
30.57%
22.96%
Tata India Pharma & Healthcare Fund Direct Growth
3/8
1,232Cr
0.63%
16.82%
26.45%
14.01%
See all
Positive: 3Y returns in the top 25% of the category
3Y returns in the top 25% of the category
Positive: Beats FD returns for both 3Y & 5Y duration
Beats FD returns for both 3Y & 5Y duration
Negative: 5Y returns in the bottom 25% of the category
5Y returns in the bottom 25% of the category

UTI Healthcare Fund Returns Calculator

Calculate SIP and lumpsum returns based on historical performance

  • 1-time

  • SIP

Total Investment

0

Profit

Total Corpus

0

Absolute Return
▲
▼

UTI Healthcare Fund Asset Allocation

See fund asset allocation details as on (14-Jun-25)

Fund Distribution

as on (14-Jun-25)

Equity 97.3%

Debt & Cash 2.7%

Small cap
41.6%
Mid cap
27.6%
Large cap
27.3%
Mid Cap allocation has gone down from 28% to 27.6%
Mid Cap allocation has gone down from 28% to 27.6%
Large Cap allocation has gone down from 28.9% to 27.3%
Large Cap allocation has gone down from 28.9% to 27.3%
Small Cap allocation has gone up from 41.1% to 41.6%
Small Cap allocation has gone up from 41.1% to 41.6%
Cash allocation has gone up from 1.1% to 2.7%
Cash allocation has gone up from 1.1% to 2.7%

UTI Healthcare Fund Sector Allocation

See fund sector allocation details as on (14-Jun-25)

Sector Allocation

Equity 97.3%

Debt & Cash 2.7%

Health
98.1%
Basic Materials
1.5%
Financial Services
0.4%

Top 2 Sectors in May were Health, Basic Materials

May'25

Health

99%

Basic Materials

1%

Apr'25

Health

99%

Basic Materials

UTI Healthcare Fund Holdings Details

as on (31-May-25)

Equity

Top Stocks bought last month
Jupiter Life Line Hospitals Ltd's allocation increased from 1.76% to 2.95%
Jupiter Life Line Hospitals Ltd's allocation increased from 1.76% to 2.95%
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 2.02% to 2.67%
Max Healthcare Institute Ltd Ordinary Shares's allocation increased from 2.02% to 2.67%
Procter & Gamble Health Ltd's allocation increased from 3.91% to 4.34%
Procter & Gamble Health Ltd's allocation increased from 3.91% to 4.34%
Top Stocks sold last month
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.88 % to 10.44 %
Sun Pharmaceuticals Industries Ltd's allocation decreased from 11.88 % to 10.44 %
Cipla Ltd's allocation decreased from 5.98 % to 5.52 %
Cipla Ltd's allocation decreased from 5.98 % to 5.52 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.89 % to 4.66 %
Dr Reddy's Laboratories Ltd's allocation decreased from 4.89 % to 4.66 %

UTI Healthcare Fund Direct Growth Overview

Get key fund statistics, minimum investment details, AUM, expense ratio, exit load, and tax treatment.

Expense ratio1.28%
Benchmark
BSE Healthcare TR INR
AUM₹1062 Cr
Inception Date1 January, 2013
Min Lumpsum/SIP₹5000/₹500
Exit Load
1.0%
Lock InNo Lock-in
TurnOver
24.75%
STCGSelling mutual fund before 1 year, returns taxed at 20%.
LTCGAfter 1 year, 12.5% tax on returns over ₹1.25 lakh/year.
Risk
Risk meter
pointer
Very High Risk

About UTI Healthcare Fund

UTI Healthcare Fund Direct Growth is an equity fund. This fund was started on 1 January, 2013. The fund is managed by . The fund could potentially beat inflation in the long-run.

Key Parameters

  1. UTI Healthcare Fund Direct Growth has ₹1062 Cr worth of assets under management (AUM) as on Jun 2025 and is more than category average.
  2. The fund has an expense ratio 1.3.

Returns

UTI Healthcare Fund Direct Growth has given a CAGR return of 16.44% since inception. Over the last 1, 3 and 5 years the fund has given a CAGR return of 22.19%, 27.62% and 22.91% respectively.

Holdings

UTI Healthcare Fund Direct Growth has allocated its funds majorly in Cash Equivalent, Health, Basic Materials. Its top holdings are Sun Pharmaceuticals Industries Ltd, Cipla Ltd, Dr Reddy's Laboratories Ltd, Procter & Gamble Health Ltd, Ajanta Pharma Ltd

Taxation

As it is a sector - healthcare mutual fund the taxation is as follows:
For short term (less than a year) capital gains will be taxed at 20%
For long term (more than 1 year) capital gains will be taxed at 12.5% without indexation benefit
Dividends will always be taxed at slab rate. Long term gains upto Rs 1 lakh are exempt capital gains tax.

Investment objective of UTI Healthcare Fund Direct Growth

The primary objective of the scheme is to generate long term capital appreciation by investing predominantly in equity and equity related securities of companies/institutions engaged in the Healthcare Services Sector. However, there can be no assurance or guarantee that the investment objective of the scheme would be achieved.

Minimum Investment and lockin period

Minimum investment for lump sum payment is INR 5000.00 and for SIP is INR 500.00. UTI Healthcare Fund Direct Growth has no lock in period.

Learn more about UTI Mutual Fund
Parameters
May'25
Apr'25
Mar'25
AUM
₹ 1.1K Cr
₹ 1K Cr
₹ 1K Cr
  • AUM of the fund stands at 1.1K Cr as of May'25
  • AUM increased by 24.7 Cr between May'25 and Apr'25

Compare UTI Healthcare Fund

UTI Healthcare Fund

VS

Nippon India Pharma Fund Direct Growth

Frequently Asked Questions for UTI Healthcare Fund Direct Growth

How do I invest in UTI Healthcare Fund?

INDmoney makes it simple to invest in the UTI Healthcare Fund. To do so, follow the steps below:
  • Download the INDmoney app.
  • Search for ‘UTI Healthcare Fund’.
  • Select whether you want to invest in SIP or lump sum.
  • Enter the amount you wish to invest.
  • Set up payments via bank mandate or UPI.

What is the current NAV of UTI Healthcare Fund?

The NAV of the fund today is ₹319.06. NAV or Net Asset Value is the per unit price of a mutual fund. For example, if the NAV of a fund is ₹10, it means you can get 1000 units of that mutual fund at ₹10,000.

What is the return on the fund?

UTI Healthcare Fund fund has generated a return of 22.19% in 1 year, 27.62% in 3 years, 22.91% in 5 years.

Who is the fund manager of UTI Healthcare Fund?

The fund managers are .

What is the exit load of the fund?

The exit load is 1% if redeemed in 0-30 Days. Exit load is a fee levied for ‘exiting’ the fund earlier than a stipulated period, usually 1 year.

What is the expense ratio of the fund?

The expense ratio is 1.28%. The Expense Ratio is a fee charged for managing the fund. This includes commissions, administrative costs etc.

What is the AUM of the fund?

The AUM of the fund is ₹1062 Cr. AUM stands for Assets Under Management. It refers to the total assets managed by the fund.

What are the top holdings of UTI Healthcare Fund?

The top 3 holdings of the fund are Sun Pharmaceuticals Industries Ltd(10.44%), Cipla Ltd(5.52%), Dr Reddy's Laboratories Ltd(4.66%)